1. Home
  2. BLFS vs VRTS Comparison

BLFS vs VRTS Comparison

Compare BLFS & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • VRTS
  • Stock Information
  • Founded
  • BLFS 1987
  • VRTS 1988
  • Country
  • BLFS United States
  • VRTS United States
  • Employees
  • BLFS N/A
  • VRTS N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • VRTS Investment Managers
  • Sector
  • BLFS Health Care
  • VRTS Finance
  • Exchange
  • BLFS Nasdaq
  • VRTS Nasdaq
  • Market Cap
  • BLFS 1.2B
  • VRTS 1.0B
  • IPO Year
  • BLFS 1989
  • VRTS 1992
  • Fundamental
  • Price
  • BLFS $23.29
  • VRTS $165.13
  • Analyst Decision
  • BLFS Strong Buy
  • VRTS Hold
  • Analyst Count
  • BLFS 7
  • VRTS 4
  • Target Price
  • BLFS $30.57
  • VRTS $167.75
  • AVG Volume (30 Days)
  • BLFS 573.8K
  • VRTS 45.7K
  • Earning Date
  • BLFS 05-08-2025
  • VRTS 04-25-2025
  • Dividend Yield
  • BLFS N/A
  • VRTS 5.46%
  • EPS Growth
  • BLFS N/A
  • VRTS 1.50
  • EPS
  • BLFS N/A
  • VRTS 16.84
  • Revenue
  • BLFS $87,762,000.00
  • VRTS $902,839,000.00
  • Revenue This Year
  • BLFS $20.32
  • VRTS N/A
  • Revenue Next Year
  • BLFS $19.98
  • VRTS N/A
  • P/E Ratio
  • BLFS N/A
  • VRTS $9.79
  • Revenue Growth
  • BLFS N/A
  • VRTS 3.84
  • 52 Week Low
  • BLFS $17.15
  • VRTS $142.18
  • 52 Week High
  • BLFS $29.55
  • VRTS $252.82
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 49.30
  • VRTS 62.56
  • Support Level
  • BLFS $21.13
  • VRTS $157.94
  • Resistance Level
  • BLFS $25.60
  • VRTS $161.67
  • Average True Range (ATR)
  • BLFS 1.58
  • VRTS 4.59
  • MACD
  • BLFS -0.07
  • VRTS 2.65
  • Stochastic Oscillator
  • BLFS 48.32
  • VRTS 100.00

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

Share on Social Networks: